Luma Group

Luma Group is an investment firm focused on the greatest breakthrough scientific discoveries that leverage advanced computation and AI. Luma invests in discovering, developing and commercializing potentially high-caliber technologies to seek to improve human health and longevity. We aim to focus on the following areas in biotech: next generation therapeutics, AI/ML enabled drug discovery platforms, AI/ML technologies transforming early disease detection and patient care, and devices and tools with advanced data capture mechanisms and analysis capabilities. Luma is led by Partners Josh Fink, Dr. Themasap Khan, PhD, and Dr. Jamie Kasuboski, PhD, each with over a decade of biotech investing and operational experience. The Luma team is backed by an advisory network that includes former C-suite executives at Fortune 500 companies, seasoned executives with strong track records in building biotech companies and healthcare leaders. We seek to leverage the Firm’s strengths to invest in companies that have strong intellectual property protections, and which address large unmet medical needs. Our mission is to work closely with portfolio companies to help them focus on addressing untapped markets and generating shareholder value.

Website

www.lumagroup.com

External link for Luma Group

Industry

Venture Capital and Private Equity Principals

Company size

2-10 employees

Headquarters

New York, New York

Type

Privately Held

Founded

2023